News | Coronavirus (COVID-19) | March 06, 2020

How Does COVID-19 Appear in the Lungs?

A Michigan Medicine radiologist teams up with a counterpart in China to examine the appearance of COVID-19 in CT scans

Chest radiograph in a patient with COVID-19 infection demonstrates right infrahilar airspace opacities #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #HIMSS20

Chest radiograph in a patient with COVID-19 infection demonstrates right infrahilar airspace opacities. Image courtesy of Radiology: Cardiothoracic Imaging

March 6, 2020 — While COVID-19, previously known as the novel coronavirus, was first reported in China, it was recently declared a global health emergency by the World Health Organization. Because most cases have been in China, clinicians elsewhere may be unfamiliar with how the virus appears in the lungs. 

Here is a VIDEO Example of COVID-19 Pneumonia Chest CT Scan Scroll Through

Find more radiology images of the various COVID presentations in this PHOTO GALLERY - How COVID-19 Appears on Medical Imaging

And reports are now showing the importance of computed tomography (CT) in diagnosis and monitoring of the infection.

“As COVID-19 continues to evolve on a global scale, it is important for radiologists to be familiar with the imaging appearance of the virus in patients,” said Prachi Agarwal, MBBS, M.D., a professor of radiology at Michigan Medicine. “Radiologic work here is extremely crucial when it comes to making diagnoses for patients.”

This inspired Agarwal to team up with Weifang Kong, M.D., a radiologist at Sichuan Provincial People’s Hospital in Chengdu, China, to examine the appearance of COVID-19 in three separate case studies involving patients with the condition.

Their research was recently published in Radiology: Cardiothoracic Imaging.

“Our work focused on the imaging appearance of COVID-19,” said Agarwal. “The radiographic and CT appearance is not specific to the disease and can be seen with other infections, too.”

The pair discovered that while the imaging appearance of COVID-19 is not specific, the presence of bilateral nodular and peripheral ground glass opacities and consolidation should serve as an alert to radiologists that COVID-19 may actually be present in certain patients.

For example, individuals who have a defined travel history to areas where others are infected by COVID-19, or have been directly exposed to others with the virus, should be examined carefully.

Agarwal adds that in radiologic terms, ‘ground glass’ means that a hazy lung opacity shows up on imaging that is not dense enough to obscure any underlying pulmonary vessels or bronchial walls. While consolidation, on the other hand, refers to dense opacities obscuring vessels and bronchial walls.

Since ground glass opacities are common in COVID-19, Agarwal notes that chest CT scans are preferred over chest radiographs, which may have limited sensitivity in picking up early changes within the lungs.

“Chest CT scans can be helpful in suggesting the diagnosis for a patient and also, for monitoring patient responses,” said Agarwal. “It’s important to note that there is a spectrum of clinical manifestations and clinical course in COVID-19. And the clinical presentation of the virus can overlap with other respiratory illnesses.”

Some patients who tested positive for COVID-19 were either asymptomatic or had minimal symptoms. And while the reference standard for making the diagnosis is a real-time reverse transcription polymerase chain reaction (RT-PCR) test, false negative results can occur.

“It has been shown that an abnormal chest CT scan can predate a positive RT-PCR, highlighting the important role of CT in the management of these patients,” said Agarwal.   

To learn more about COVID-19, visit: What Can You Do to Protect Against Coronavirus?

How COVID-19 Appears on Medical Imaging

 

Additional COVID-19 Resources for Clinicians:

World Health Organization (WHO) COVID-19 situation reports

World Health Organization (WHO) coronavirus information page

U.S. Food and Drug Administration (FDA) COVID-19 information page

Centers for Disease Control (CDC) COVID-19 information page

 

RELATED CORONAVIRUS CONTENT:

The Cardiac Implications of Novel Coronavirus

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Radiology Lessons for Coronavirus From the SARS and MERS Epidemics

Deployment of Health IT in China’s Fight Against the COVID-19 Epidemic

Emerging Technologies Proving Value in Chinese Coronavirus Fight

Radiologists Describe Coronavirus CT Imaging Features

Coronavirus Update from the FDA

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia 

Find more related clinical content Coronavirus (COVID-19)

Related Content

The U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.
News | Artificial Intelligence | January 12, 2021
January 12, 2021 — The U.S.
Myocarditis among recovering COVID-19 athletes less common than previously reported

Getty Images

News | Cardiac Imaging | January 11, 2021
January 11, 2021 — In a letter published in the December issue of the American Heart Association's...
Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound.

Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound. Image courtesy of UVA Health

News | Focused Ultrasound Therapy | January 08, 2021
January 8, 2021 — A scalpel-free alternative to brain surgery has the potential to benefit people with...
The FDA is monitoring the potential impact of viral mutations, including an emerging variant from the United Kingdom known as the B.1.1.7 variant, on authorized SARS-CoV-2 molecular tests

Getty Images

News | Coronavirus (COVID-19) | January 08, 2021
January 8, 2021 — The U.S.
World-first techniques for predicting breast cancer risk from mammograms that were developed in Melbourne could revolutionise breast screening by allowing it to be tailored to women at minimal extra cost

Getty Images

News | Mammography | January 06, 2021
January 6, 2021 — World-first techniques for predicting breast cancer risk from...
Transaction accelerates Hologic’s entry into oncology growth market, provides new lab capabilities

Getty Images

News | Breast Imaging | January 06, 2021
January 6, 2021 — Hologic, Inc., a global leader in women's...
In this roundtable discussion hosted by ITN Editorial Director Melinda Taschetta-Millane, three medical experts will discuss the impact COVID-19 had on the industry in 2020, as well as projections for the industry in 2021.
Webinar | Coronavirus (COVID-19) | January 06, 2021
2020 was an unprecedented year, as the world grappled with a...
OptumInsight and Change Healthcare combine to advance a more modern, information and technology-enabled healthcare platform

Getty Images

News | Information Technology | January 06, 2021
January 6, 2020 — Optum, a diversified health services company and
Who should get the COVID vaccine? Roberto Lang, M.D., director of noninvasive cardiac imaging, University of Chicago Medical Center and former American Society of Echocardiography (ASE) president, received his first dose of the COVID vaccine in December. In addition to front line hospital workers, nursing home staff and residents also qualified for the first round of vaccinations. Right, Shannon Yaw, a nurse at a hard-hit nursing home in Michigan, received her first dose just before Christmas.

Roberto Lang, M.D., director of noninvasive cardiac imaging, University of Chicago Medical Center and former American Society of Echocardiography (ASE) president, received his first dose of the COVID vaccine in December. In addition to front line hospital workers, nursing home staff and residents also qualified for the first round of vaccinations. Right, Shannon Yaw, OTR/L, director of rehabilitation at a hard-hit nursing home in Michigan, received her first dose just before Christmas. nurse at a hard-hit nursing home in Michigan, received her first dose just before Christmas.

News | Coronavirus (COVID-19) | January 04, 2021
The Centers for Disease Control and Prevention (CDC) Dec.
Smart Breast Corporation (SmartBreast), a privately held company focused on breast cancer screening and detection, announced today that it has acquired certain molecular breast imaging (MBI) assets from Dilon Technologies, Inc. (Dilon) for an undisclosed amount.
News | Breast Imaging | January 04, 2021
January 4, 2021 — Smart Breast Corporation (SmartBreast), a privately held company focused on...